Fox K A, Bergmann S R, Sobel B E
Annu Rev Med. 1985;36:125-44. doi: 10.1146/annurev.me.36.020185.001013.
The feasibility of myocardial reperfusion induced by coronary thrombolysis stimulated marked changes in the management of patients with acute myocardial infarction. Despite the demonstrable successful recanalization achieved in many patients, effective tissue reperfusion has not necessarily been achieved. Furthermore, factors defining the risk/benefit relationships of reperfusion, the extent to which salutary effects on jeopardized myocardium can be anticipated, and the ultimate long-term benefit conferred on the patient all require further definition. Widespread implementation of interventions utilized to induce myocardial reperfusion should be based on thorough characterization of the functional and metabolic responses of the heart to reperfusion. This selective review considers reperfusion within the context of an extensive body of information pertinent to the pathophysiological mechanisms underlying ischemic injury and discusses the potential favorable and unfavorable responses to reperfusion.
冠状动脉溶栓诱导心肌再灌注的可行性引发了急性心肌梗死患者治疗的显著变化。尽管许多患者实现了可证明的成功再通,但不一定实现了有效的组织再灌注。此外,定义再灌注风险/益处关系的因素、对濒危心肌预期有益作用的程度以及赋予患者的最终长期益处都需要进一步明确。用于诱导心肌再灌注的干预措施的广泛实施应基于对心脏对再灌注的功能和代谢反应的全面表征。这篇选择性综述在与缺血性损伤潜在病理生理机制相关的大量信息背景下考虑再灌注,并讨论对再灌注潜在的有利和不利反应。